AstraZeneca shows cardiovascular safety for roxadustat in global Phase III trials Farhat Nasim12 May 2019 10:15 AM ISTNew Delhi: AstraZeneca recently announced top-line results from the pooled cardiovascular (CV) safety analyses of the global Phase III programme for...
Strides Pharma reports Q4 profit after tax at Rs 43.81 crore Garima12 May 2019 10:00 AM ISTMoving into the new financial year, Strides Pharma Science's emerging market and institutional business will get the highest attention and...
Pfizer acquires clinical-stage Biotech Therachon for $810 million Garima12 May 2019 9:45 AM ISTNEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions Farhat Nasim12 May 2019 9:30 AM ISTWeekly U.S. prescription data from IQVIA, an analytics provider to the life sciences industry, showed that Lilly's therapy Emgality claimed the...
Netmeds to add dozen more fulfillment centers in India by 2020 Medical Dialogues Bureau12 May 2019 9:29 AM ISTChennai: Online pharmacy Netmeds.com Thursday said it will add 12 fulfilment centres across the country by 2020 in an effort to facilitate quick...
Indoco Remedies' new solid dosages facility at Baddi gets UK-MHRA nod Farhat Nasim11 May 2019 10:00 AM ISTIndoco Remedies' new Baddi facility is spread over an area of 18000 sqm, with a manufacturing capacity of 4.3 billion tablets and 50 million capsules...
Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy Farhat Nasim11 May 2019 9:15 AM ISTNew Delhi: Pfizer Inc's subsidiary FoldRx, has recently won U.S. Food and Drug Administration (USFDA) approved for Vyndaqel (tafamidis meglumine) and...
Indivior signs deal to sell schizophrenia drug Perseris in Canada Garima11 May 2019 9:10 AM ISTPerseris, launched in the United States in February, is approved by the FDA for the treatment of schizophrenia in adults.U.S: British drugmaker...
Following opioid suits, family behind deadly OxyContin squabbles Medical Dialogues Bureau11 May 2019 9:00 AM ISTNEW YORK: A united front among members of the billionaire Sackler family behind painkiller OxyContin is showing signs of strain from litigation over...
JnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCA Meghna A Singhania10 May 2019 12:40 PM ISTAhmedabad: In a major relief, the notable MNC Johnson and Johnson (JnJ) has received clearance from the Gujarat Food and Drugs Control Administration...
Lupin launches generic Clobazam tablets to treat seizures Farhat Nasim10 May 2019 10:45 AM ISTThe company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug...
Lupin, Aptissen sign pact to sell Osteoarthritis injection Synolis in Canada Garima10 May 2019 9:30 AM ISTSynolis VA (Visco-Antalgic) is the intra-articular injection product for osteoarthritis with a unique combination of Hyaluronic Acid and high...
